Columbia Laboratories, Inc.'s Painful-Menstruation Drug Fails Trial

Sept 29 (Reuters) - Columbia Laboratories Inc said its experimental treatment for painful menstruation failed to meet the main goal in a mid-stage trial.
MORE ON THIS TOPIC